Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | lamin dm0 | 0.0028 | 0.1056 | 0.1023 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0038 | 0.1772 | 0.1743 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.1772 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0131 | 0.8445 | 0.844 |
Brugia malayi | intermediate filament protein | 0.0028 | 0.1056 | 0.0928 |
Schistosoma mansoni | tar DNA-binding protein | 0.0131 | 0.8445 | 1 |
Leishmania major | phosphopantetheinyl transferase-like protein | 0.0024 | 0.0794 | 1 |
Schistosoma mansoni | aminoadipate-semialdehyde dehydrogenase | 0.0085 | 0.516 | 0.5886 |
Mycobacterium tuberculosis | holo-[acyl-carrier protein] synthase AcpS (holo-ACP synthase) (CoA:APO-[ACP]pantetheinephosphotransferase) (CoA:APO-[acyl-carrie | 0.0024 | 0.0794 | 1 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0019 | 0.0459 | 0.5 |
Brugia malayi | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | 0.0085 | 0.516 | 0.5091 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.1772 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0085 | 0.516 | 0.516 |
Mycobacterium ulcerans | 4'-phosphopantetheinyl transferase | 0.0024 | 0.0794 | 1 |
Schistosoma mansoni | lamin | 0.0028 | 0.1056 | 0.0747 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0131 | 0.8445 | 0.8445 |
Entamoeba histolytica | hypothetical protein | 0.0024 | 0.0794 | 0.2547 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0153 | 1 | 1 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0019 | 0.0459 | 0.0323 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0038 | 0.1772 | 0.1743 |
Brugia malayi | hypothetical protein | 0.0038 | 0.1772 | 0.1655 |
Loa Loa (eye worm) | hypothetical protein | 0.0153 | 1 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0024 | 0.0794 | 1 |
Echinococcus multilocularis | muscleblind protein | 0.0153 | 1 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0131 | 0.8445 | 0.8445 |
Echinococcus granulosus | L aminoadipate semialdehyde | 0.0085 | 0.516 | 0.5143 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0028 | 0.1056 | 0.1056 |
Echinococcus granulosus | lamin | 0.0028 | 0.1056 | 0.1023 |
Toxoplasma gondii | 4'-phosphopantetheinyl transferase domain-containing protein | 0.0024 | 0.0794 | 1 |
Chlamydia trachomatis | holo [acyl-carrier protein] synthase | 0.0024 | 0.0794 | 0.5 |
Loa Loa (eye worm) | intermediate filament protein | 0.0028 | 0.1056 | 0.1056 |
Schistosoma mansoni | intermediate filament proteins | 0.0028 | 0.1056 | 0.0747 |
Schistosoma mansoni | tar DNA-binding protein | 0.0131 | 0.8445 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0131 | 0.8445 | 1 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0019 | 0.0459 | 0.0425 |
Echinococcus granulosus | lamin dm0 | 0.0028 | 0.1056 | 0.1023 |
Wolbachia endosymbiont of Brugia malayi | 4'-phosphopantetheinyl transferase | 0.0024 | 0.0794 | 1 |
Onchocerca volvulus | 0.0085 | 0.516 | 1 | |
Brugia malayi | RNA recognition motif domain containing protein | 0.0131 | 0.8445 | 0.8423 |
Plasmodium falciparum | holo-[acyl-carrier-protein] synthase, putative | 0.0024 | 0.0794 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.1772 | 1 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0019 | 0.0459 | 0.5 |
Echinococcus granulosus | muscleblind protein | 0.0153 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.102 | 0.102 |
Schistosoma mansoni | lamin | 0.0028 | 0.1056 | 0.0747 |
Schistosoma mansoni | hypothetical protein | 0.0038 | 0.1772 | 0.1644 |
Brugia malayi | RNA binding protein | 0.0131 | 0.8445 | 0.8423 |
Echinococcus multilocularis | lamin | 0.0028 | 0.1056 | 0.1023 |
Plasmodium vivax | holo-[acyl-carrier-protein] synthase, putative | 0.0024 | 0.0794 | 1 |
Treponema pallidum | 4'-phosphopantetheinyl transferase | 0.0024 | 0.0794 | 1 |
Echinococcus multilocularis | L aminoadipate semialdehyde | 0.0085 | 0.516 | 0.5143 |
Loa Loa (eye worm) | hypothetical protein | 0.0013 | 0.0036 | 0.0036 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0038 | 0.1772 | 0.1644 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0015 | 0.0141 | 0.0141 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.1056 | 0.1056 |
Schistosoma mansoni | tar DNA-binding protein | 0.0131 | 0.8445 | 1 |
Toxoplasma gondii | 4'-phosphopantetheinyl transferase superfamily protein | 0.0024 | 0.0794 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0131 | 0.8445 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0153 | 1 | 1 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0028 | 0.1056 | 0.0928 |
Echinococcus granulosus | tar DNA binding protein | 0.0131 | 0.8445 | 0.844 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0019 | 0.0459 | 0.0459 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0.0459 | 0.5 |
Mycobacterium ulcerans | phosphopantetheinyl transferase, PptII | 0.0024 | 0.0794 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0131 | 0.8445 | 0.8445 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0.0459 | 0.5 |
Mycobacterium leprae | conserved hypothetical protein | 0.0024 | 0.0794 | 0.5 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0019 | 0.0459 | 0.5 |
Echinococcus granulosus | intermediate filament protein | 0.0028 | 0.1056 | 0.1023 |
Echinococcus multilocularis | musashi | 0.0028 | 0.1056 | 0.1023 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0019 | 0.0459 | 0.0425 |
Brugia malayi | TAR-binding protein | 0.0131 | 0.8445 | 0.8423 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.1772 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.